Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers
- DOI
- 10.3389/fonc.2026.1812790
- Published
- 2026-03-16
- Container
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1812790,
title = {Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers},
author = {Wanying Li and Ziyang Wang and Xiaoliang Chen and Yong Qin and Dong Dai},
year = {2026},
journal = {Frontiers in Oncology},
doi = {10.3389/fonc.2026.1812790},
url = {https://doi.org/10.3389/fonc.2026.1812790}
}RIS
TY - JOUR TI - Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers AU - Wanying Li AU - Ziyang Wang AU - Xiaoliang Chen AU - Yong Qin AU - Dong Dai PY - 2026 JO - Frontiers in Oncology DO - 10.3389/fonc.2026.1812790 UR - https://doi.org/10.3389/fonc.2026.1812790 ER -
APA
Li, W., Wang, Z., Chen, X., Qin, Y., & Dai, D. (2026). Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1812790
Source records
- crossref · retrieved 2026-09-27T13:07:12.790Z